TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
IMMX

Immix Biopharma Inc

Healthcare · Biotechnology

12.50$ -0.2% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow IMMX
Line item 2019 2020 2021 2022 2023 2024 2025
+114.5% +6.3% -13.5% +156.1% +2,010.2% +215.9%
+185.0% +311.1% +17.7% -19.2%
+0.0% +3,921.7% -97.3%
-8.7% -335.8% +746.8% +140.0% -31.9%
-99.9% +19,950.0% -99.6% +1,736,200.0% +2,160.9% -37.8%
-89.0% +0.0% +2,160.9% +512.5%
-56.0%
-81.0% +0.0% -125.0% -100.0%
+1,695.1% +0.0% -82.9% +378.4% +3.1% +573.3%
-226.2% -124.4% -95.8% +44,187.5%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?